Search
Search Results
##search.searchResults.foundPlural##
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1581PDF: 904HTML: 3155 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4173PDF: 1234HTML: 482 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3601PDF: 640HTML: 738 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1598PDF: 1430HTML: 125 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3517PDF: 1699HTML: 301 -
A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report
59PDF: 36Suppl. Files: 11Html: 26Html Suppl. Files: 11 -
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1465PDF: 662HTML: 1127 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1423PDF: 547HTML: 8370 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
901PDF: 346Html: 53 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
877PDF: 725HTML: 140 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3764PDF: 1648HTML: 4561CoverLetter: 288Figure1: 307 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1235PDF: 1442HTML: 187 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2880PDF: 1120HTML: 2405 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1996PDF: 870HTML: 3703 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1533PDF: 784HTML: 1202Untitled: 232Untitled: 204Untitled: 188Untitled: 201Untitled: 213 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3396PDF: 1266HTML: 524 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1536PDF: 989HTML: 436 -
Simultaneous dual pathology in lymph node
1773PDF: 779HTML: 7870Simultaneous dual pathology in lymph node: 221Simultaneous dual pathology in lymph node: 238Simultaneous dual pathology in lymph node: 195Simultaneous dual pathology in lymph node: 238Simultaneous dual pathology in lymph node: 232 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1722PDF: 989HTML: 411 -
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
1073PDF: 661HTML: 237 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3857PDF: 2666HTML: 1716 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1788PDF: 1163HTML: 519







